Work

Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer

Year: 2018

Type: erratum

Source: Investigational New Drugs

DOI: 10.1007/s10637-018-0679-5

Authors: Laura W. Goff, Nilofer S. Azad, Stacey Stein, Jennifer G. Whisenant, Tatsuki Koyama, Ulka Vaishampayan, Howard Hochster, Roisin Connolly, Amy Weise, Patricia M. LoRusso, Safia N. Salaria, Wael El-Rifai, Jordan D. Berlin

Institutions: Vanderbilt University, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Yale Cancer Center, The Barbara Ann Karmanos Cancer Institute, Rutgers, The State University of New Jersey, University of Miami, Sylvester Comprehensive Cancer Center

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2897599167

Cites:

Cited by:

Related to: 10